Health Care Provider Education Clinical Trial
— CTPCOfficial title:
Palliative Care Provider Online Education in Evidence-Based Complementary Therapies
Verified date | December 2015 |
Source | Collinge and Associates, Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
Palliative care represents one of the most rapidly expanding sectors of health care. Its rapid growth has been accompanied by widespread needs for training of multidisciplinary personnel to work with the unique set of health issues specific to its population of patients - not only those at end-of-life, but also patients with long-term, incurable, chronic and degenerative illnesses. This project will develop the first online continuing education program for palliative care personnel in the evidence-based application of complementary therapies, to enhance patient care and quality of life in the palliative care setting.
Status | Completed |
Enrollment | 51 |
Est. completion date | December 2013 |
Est. primary completion date | December 2013 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Physicians (MD, DO), physician assistant (PA), nurse practitioner (NP), registered nurse (RN), licensed practical nurse (LPN), social worker (BA/BS/BSW, MSW, PhD/DSW), psychologist (MS/MA, PhD/PsyD), counselor (MS/MA),administrator, and chaplain. - Must be currently active within palliative care settings. Exclusion Criteria: - Professionals not actively working in palliative care settings |
Intervention Model: Single Group Assignment, Masking: Open Label
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Collinge and Associates, Inc. | Kozak & Associates, LLC |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Investigator-generated test of course content | Change in knowledge about theory, mechanisms of action, delivery, indications for use, evidence of efficacy | Baseline, 30 days | No |
Secondary | Investigator-generated scale of confidence in understanding modality safety considerations | Change in confidence in understanding the modality's safety considerations in PC | Baseline, 30 days | No |
Secondary | Investigator-generated scale of confidence in making evidence-based recommendations about the modality | Change in confidence in making evidence-based recommendations for the modality in PC planning | Baseline, 30 days | No |
Secondary | Investigator-generated scale of confidence in communicating about the modality | Change in confidence in ability to explain use of the modality to patients, families and colleagues in PC contexts | Baseline, 30 days | No |
Secondary | Investigator-generated scale of perceived course relevance | User perceived importance and relevance of course content, and potential to improve patient care | 30 days | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02379234 -
Simulation for Continuous Veno-venous Hemofiltration in Intensive caRe
|
N/A |